These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 496881)
1. Hemorrheological abnormalities in different states of diabetic retinopathy. Effect of metabolic control and subsequent diseases. Volger E Bibl Anat; 1979; (18):60-6. PubMed ID: 496881 [TBL] [Abstract][Full Text] [Related]
2. Effect of metabolic control and concomitant diseases upon the rheology of blood in different states of diabetic retinopathy. Volger E Horm Metab Res Suppl; 1981; 11():104-7. PubMed ID: 6947946 [TBL] [Abstract][Full Text] [Related]
3. Red-cell aggregation and red-cell deformability in diabetes. Schmid-Schönbein H; Volger E Diabetes; 1976; 25(2 SUPPL):897-902. PubMed ID: 971793 [TBL] [Abstract][Full Text] [Related]
4. [Blood viscosity and erythrocyte deformability in diabetic retinopathy]. Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016 [TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus: its effect on the flow properties of blood. Oughton J; Barnes AJ; Kohner EM Horm Metab Res Suppl; 1981; 11():112-20. PubMed ID: 6797911 [TBL] [Abstract][Full Text] [Related]
6. [Hemorheologic findings in diabetes and their clinical relevance]. Volger E Wien Med Wochenschr; 1986; 136 Spec No():5-10. PubMed ID: 3825172 [TBL] [Abstract][Full Text] [Related]
7. [Rheologic findings in patients with diabetic retinopathy]. Bertram B; Wolf S; Kaufhold F; Jung F; Kiesewetter H; Reim M Fortschr Ophthalmol; 1991; 88(4):321-5. PubMed ID: 1786912 [TBL] [Abstract][Full Text] [Related]
8. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Chung TW; Yu JJ; Liu DZ Diabet Med; 1998 May; 15(5):380-5. PubMed ID: 9609359 [TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations]. Benhamou PY; Carpentier P; Halimi S; Bertrand C; Mouillon M; Franco A Diabete Metab; 1990; 16(3):192-8. PubMed ID: 2210013 [TBL] [Abstract][Full Text] [Related]
10. [Blood rheology abnormalities in diabetes mellitus]. Le Devehat C J Mal Vasc; 1989; 14(1):64-7. PubMed ID: 2646390 [TBL] [Abstract][Full Text] [Related]
11. Rheological changes in diabetic microangiopathy. Negrean V; Suciu I; Sâmpelean D; Cozma A Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630 [TBL] [Abstract][Full Text] [Related]
12. [Modification of hemorheological parameters in microvascular complications of diabetes]. Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810 [TBL] [Abstract][Full Text] [Related]
13. Activity of Daflon 500 mg on the hemorheological disorders in diabetes. Lacombe C; Lelievre JC; Bucherer C; Grimaldi A Int Angiol; 1989; 8(4 Suppl):45-8. PubMed ID: 2632648 [TBL] [Abstract][Full Text] [Related]
15. [Effect of rheological factors on diabetic microangiopathies: is there an effective medical treatment for diabetic retinopathy?]. Meunier I; Soubrane G; Coscas G Bull Soc Belge Ophtalmol; 1995; 256():67-70. PubMed ID: 8581233 [TBL] [Abstract][Full Text] [Related]